Skip to main content
. Author manuscript; available in PMC: 2021 Jan 6.
Published in final edited form as: Cell Rep. 2020 Nov 25;33(10):108406. doi: 10.1016/j.celrep.2020.108406

Table 2.

Relationships of Mission Duration with Aging Biomarkers and Leukocyte Proportions

Difference in DNA Methylation Marker (95% CI) Aging Biomarker Modela pb
DNAmGrimAge (Years)
Baseline (−7 days) reference ND
60 days −0.52 (−2.72 to 1.67) 0.65
168 days −4.50 (−6.79 to 2.20) 0.001
300 days −2.12 (−4.41 to 0.17) 0.09
512 days 0.38 (−2.35 to 3.10) 0.79
Post-mission (527 days) 0.06 (−2.35 to 2.47) 0.96
DNAmPhenoAge (Years)
Baseline (−7 days) reference ND
60 days −2.39 (−5.38 to 0.61) 0.11
168 days −5.90 (−9.03 to −2.77) 0.001
300 days −4.14 (−7.27 to −1.02) 0.01
512 days −3.04 (−6.76 to 0.68) 0.10
Post-mission (527 days) −5.41 (−8.70 to −2.12) 0.003
DNAmTL (kb)
Baseline (−7 days) reference ND
60 days 0.03 (−0.07 to 0.14) 0.48
168 days 0.02 (−0.08 to 0.12) 0.67
300 days 0.02 (−0.09 to 0.13) 0.70
512 days 0.03 (−0.08 to 0.14) 0.58
Post-mission (527 days) −0.01 (−0.11 to 0.08) 0.76
Pace of Aging (PoA) (Years)
Baseline (−7 days) reference ND
60 days 0.03 (−0.02 to 0.09) 0.19
168 days 0.01 (−0.04 to 0.07) 0.60
300 days −0.01 (−0.07 to 0.05) 0.65
512 days 0.04 (−0.02 to 0.10) 0.15
Post-mission (527 days) 0.002 (−0.05 to 0.05) 0.94
Mitotic Age (epiTOC2) (Divisions per Stem Cell per Year)
Baseline (−7 days) reference ND
60 days −397.21 (−710.69 to −83.73) 0.02
168 days −481.53 (−806.91 to −156.16) 0.006
300 days −137.62 (−463.80 to 188.56) 0.39
512 days −313.55 (−698.51 to 71.40) 0.10
Post-mission (527 days) −216.67 (−557.20 to 123.87) 0.20
DNAmGrimAge Component Modela
DNAm ADM (pg/mL)
Baseline (−7 days) reference ND
60 days −9.21 (−18.72 to 0.31) 0.07
168 days −22.66 (−32.60 to −12.72) 0.0003
300 days −12.02 (−21.95 to −2.08) 0.03
512 days −0.62 (−12.44 to 11.19) 0.92
Post-mission (527 days) −2.53 (−12.99 to 7.93) 0.64
DNAm B2M (pg/mL)
Baseline (−7 days) reference ND
60 days −11,537.7 (−54,851.00 to 31,775.68) 0.58
168 days −46,459.3 (−90,099.30 to −28,19.31) 0.04
300 days −42,559.8 (−87,307.27 to 2,187.72) 0.06
512 days 17,348.3 (−31,813.55 to 66,510.23) 0.47
Post-mission (527 days) 21,684.3 (21,852.57 to 65,221.21) 0.31
DNAm Cystatin C (pg/mL)
Baseline (−7 days) reference ND
60 days 8,025.9 (−11,508.78 to 27,560.51) 0.40
168 days −4,456.8 (−24,120.16 to 15,206.56) 0.64
300 days −5,041.1 (−25,701.20 to 15,619.04) 0.61
512 days −5,248.7 (−26,859.24 to 16,361.76) 0.62
Post-mission (527 days) 7,124.1 (−12,024.12 to 26,272.35) 0.44
DNAm GDF-15 (pg/mL)
Baseline (−7 days) reference ND
60 days −36.51 (−103.14 to 30.12) 0.26
168 days −96.62 (−164.04 to −29.20) 0.008
300 days −39.12 (−111.96 to 33.71) 0.27
512 days 10.92 (−61.50 to 83.35) 0.76
Post-mission (527 days) −19.67 (−83.85 to 44.51) 0.53
DNAm Leptin (pg/mL)
Baseline (−7 days) reference ND
60 days 1,225.78 (−57.88 to 2,509.45) 0.06
168 days −168.65 (−1,463.03 to 1,125.73) 0.79
300 days 188.22 (−1,135.56 to 1,512.00) 0.77
512 days −306.50 (−1,769.60 to 1,156.60) 0.67
Post-mission (527 days) 360.37 (−935.18 to 1,655.92) 0.57
DNAm Packyears (Pack-Years)
Baseline (−7 days) reference ND
60 days 0.36 (−3.11 to 3.84) 0.83
168 days 0.14 (−3.40 to 3.67) 0.94
300 days 0.70 (−2.87 to 4.28) 0.68
512 days 1.21 (−2.87 to 5.29) 0.54
Post-mission (527 days) 0.77 (−2.84 to 4.38) 0.66
DNAm PAI-1 (pg/mL)
Baseline (−7 days) reference ND
60 days 1,160.27 (−383.77 to 2,704.31) 0.13
168 days −1,364.61 (−2,920.97 to 191.75) 0.08
300 days 261.24 (−1,390.39 to 1,912.88) 0.74
512 days −218.50 (−1,914.57 to 1,477.58) 0.79
Post-mission (527 days) −132.06 (−1,635.02 to 1,370.91) 0.86
DNAm TIMP-1 (pg/mL)
Baseline (−7 days) Reference ND
60 days −170.00 (−683.06 to 343.07) 0.50
168 days −681.05 (−1,198.05 to−164.04) 0.01
300 days −280.04 (−809.90 to 249.82) 0.28
512 days 71.26 (−511.54 to 654.06) 0.80
Post-mission (527 days) 57.91 (−458.20 to 574.01) 0.82
Leukocyte Modelc
B Cells
Baseline (−7 days) reference ND
60 days −0.003 (−0.02 to 0.01) 0.65
168 days −0.00005 (−0.02 to 0.01) 0.99
300 days 0.02 (0.001 to 0.03) 0.03
512 days 0.02 (0.002 to 0.03) 0.03
Post-mission (527 days) −0.003 (−0.02 to 0.01) 0.73
CD4 Naive Cells
Baseline (−7 days) reference
60 days −53.30 (−111.04 to 4.44) 0.07
168 days −84.27 (−142.01 to −26.54) 0.01
300 days −11.06 (−68.80 to 46.67) 0.70
512 days 41.34 (−16.39 to 99.08) 0.15
Post-mission (527 days) −36.39 (−94.12 to 21.35) 0.21
CD4 T Cells
Baseline (−7 days) reference ND
60 days 0.01 (−0.02 to 0.04) 0.54
168 days 0.001 (−0.03 to 0.03) 0.96
300 days 0.06 (0.03 to 0.09) 0.0008
512 days 0.05 (0.02 to 0.09) 0.003
Post-mission (527 days) −0.001 (−0.03 to 0.03) 0.93
CD8 Naive Cells
Baseline (−7 days) reference ND
60 days −20.67 (−40.00 to −1.36) 0.04
168 days −8.23 (−27.55 to 11.09) 0.39
300 days 1.27 (−18.05 to 20.59) 0.89
512 days 37.95 (18.63 to 57.27) 0.0004
Post-mission (527 days) 1.13 (−18.19 to 20.45) 0.91
CD8pCD28nCD45Ran T Cells
Baseline (−7 days) reference ND
60 days 1.36 (−1.06 to 3.79) 0.26
168 days 1.76 (−0.67 to 4.18) 0.15
300 days −1.39 (−3.81 to 1.03) 0.25
512 days 0.03 (−2.39 to 2.45) 0.98
Post-mission (527 days) 1.76 (−0.66 to 4.18) 0.15
CD8 T Cells
Baseline (−7 days) reference ND
60 days −0.01 (−0.04 to 0.01) 0.31
168 days −0.03 (−0.06 to −0.003) 0.03
300 days −0.002 (−0.03 to 0.02) 0.86
512 days 0.02 (−0.007 to 0.05) 0.14
Post-mission (527 days) −0.02 (−0.04 to 0.008) 0.17
Granulocytes
Baseline (−7 days) reference ND
60 days 0.01 (−0.04 to 0.06) 0.70
168 days 0.04 (−0.008 to 0.09) 0.10
300 days 0.0008 (−0.05 to 0.05) 0.98
512 days −0.05 (−0.10 to 0.002) 0.06
Post-mission (527 days) 0.05 (0.0009 to 0.10) 0.05
Monocytes
Baseline (−7 days) reference ND
60 days 0.02 (0.002 to 0.03) 0.03
168 days 0.01 (−0.004 to 0.03) 0.15
300 days −0.01 (−0.03 to 0.0002) 0.05
512 days −0.01 (−0.02 to 0.007) 0.30
Post-mission (527 days) 0.002 (−0.01 to 0.02) 0.74
NK Cells
Baseline (−7 days) reference ND
60 days −0.03 (−0.06 to −0.005) 0.02
168 days −0.02 (−0.04 to 0.01) 0.29
300 days −0.05 (−0.08 to −0.02) 0.002
512 days −0.03 (−0.06 to −0.004) 0.03
Post-mission (527 days) −0.04 (−0.07 to −0.007) 0.02
Plasmablasts
Baseline (−7 days) reference ND
60 days −0.02 (−0.13 to 0.08) 0.64
168 days 0.03 (−0.07 to 0.14) 0.53
300 days −0.17 (−0.27 to −0.06) 0.003
512 days −0.17 (−0.28 to −0.07) 0.003
Post-mission (527 days) −0.02 (−0.12 to 0.09) 0.71
a

Models adjusted for baseline DNAmAgeSkinBloodClock and white blood cell proportions.

b

Italicized p values are considered statistically significant in these analyses. ND, no data.

c

Models adjusted for baseline DNAmAgeSkinBloodClock.